GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GENinCode PLC (LSE:GENI) » Definitions » Cash From Discontinued Investing Activities

GENinCode (LSE:GENI) Cash From Discontinued Investing Activities : £0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is GENinCode Cash From Discontinued Investing Activities?

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

GENinCode's cash from discontinued investing activities for the six months ended in Dec. 2024 was £0.00 Mil. It means GENinCode received £0.00 Mil from discontinued investing activities. GENinCode's cash from discontinued investing activities for the trailing twelve months (TTM) ended in Dec. 2024 was £0.00 Mil.


GENinCode Cash From Discontinued Investing Activities Historical Data

The historical data trend for GENinCode's Cash From Discontinued Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GENinCode Cash From Discontinued Investing Activities Chart

GENinCode Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash From Discontinued Investing Activities
Get a 7-Day Free Trial - - - - -

GENinCode Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash From Discontinued Investing Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

GENinCode Cash From Discontinued Investing Activities Calculation

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Cash From Discontinued Investing Activities for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GENinCode Cash From Discontinued Investing Activities Related Terms

Thank you for viewing the detailed overview of GENinCode's Cash From Discontinued Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


GENinCode Business Description

Industry
Traded in Other Exchanges
Address
Oxford Science Park, John Eccles House, Robert Robertson Avenue, Oxford, GBR, OX4 4GP
GENinCode PLC is engaged in the genetic risk assessment, prediction, and prevention of cardiovascular diseases including coronary artery diseases such as angina and myocardial infarction (heart attack), stroke, heart failure, hypertension, and other vascular heart diseases. The company's current product portfolio comprises Cardio inCode, LiPID inCode, SuDD inCode, and Thrombo inCode. The company has only one reportable segment the sale of kits and the provision of support services. The Geographic Markets of the group are Chile, France, Italy, Sweden, Mexico, Spain, and the United Kingdom.